Predilife (ALPRE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.219x

Based on the latest financial reports, Predilife (ALPRE) has a cash flow conversion efficiency ratio of 0.219x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.28 Million ≈ $-1.49 Million USD) by net assets (€-5.82 Million ≈ $-6.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Predilife to measure how many days the company can operate on defensive assets alone.

Predilife - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Predilife's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Predilife Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Predilife ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CBL International Limited Ordinary Shares NASDAQ:BANL	-0.025x
InnSuites Hospitality Trust NYSE MKT:IHT	0.988x
Satria Antaran Prima Tbk PT JK:SAPX	0.018x
Sirona Biochem Corp V:SBM	0.160x
Gurktaler Aktiengesellschaft VI:GAGV	N/A
AUGA GROUP AB EO 029 F:W9Z	0.032x
S. Pack & Print Public Company Limited BK:SPACK	0.013x
Guideline Geo AB (publ) ST:GGEO	0.072x

Annual Cash Flow Conversion Efficiency for Predilife (2016–2024)

The table below shows the annual cash flow conversion efficiency of Predilife from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see ALPRE market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-4.27 Million ≈ $-4.99 Million	€-3.72 Million ≈ $-4.35 Million	0.872x	+110.59%
2023-12-31	€513.52K ≈ $600.36K	€-4.23 Million ≈ $-4.94 Million	-8.236x	-1502.63%
2022-12-31	€-5.22 Million ≈ $-6.10 Million	€-3.07 Million ≈ $-3.58 Million	0.587x	-75.98%
2021-12-31	€-1.57 Million ≈ $-1.83 Million	€-3.83 Million ≈ $-4.47 Million	2.445x	+183.67%
2020-12-31	€721.69K ≈ $843.73K	€-2.11 Million ≈ $-2.47 Million	-2.922x	-193.26%
2019-12-31	€-764.29K ≈ $-893.53K	€-2.39 Million ≈ $-2.80 Million	3.133x	-97.90%
2018-12-31	€-12.10K ≈ $-14.15K	€-1.81 Million ≈ $-2.11 Million	149.479x	+12560.50%
2017-12-31	€-1.29 Million ≈ $-1.51 Million	€-1.53 Million ≈ $-1.78 Million	1.181x	+131.59%
2016-12-31	€362.63K ≈ $423.95K	€-1.36 Million ≈ $-1.58 Million	-3.737x	--

About Predilife

PA:ALPRE France Diagnostics & Research

Market Cap

$11.23 Million

€9.60 Million EUR

Market Cap Rank

#26758 Global

#459 in France

Share Price

€2.45

Change (1 day)

+1.24%

52-Week Range

€2.42 - €3.74

All Time High

€15.90